Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer
screening (LCS) with low-dose CT reduces mortality among high-risk current and former …

Background Targeted lung cancer screening is effective in reducing mortality by upwards of
twenty percent. However, screening is not universally available and uptake is variable and …

Background Low-dose computed tomography (LDCT) scan for lung cancer screening is
underutilized. Studies suggest that up to one-third of providers do not know the current lung …

Rationale: Lung cancer screening has a mortality benefit to high-risk smokers, but
implementation remains suboptimal. Providers represent the key entry point to screening …

Lung cancer screening is just starting to be implemented across the United States.
Challenges to screening include access to care, awareness of the option for screening …

Background The purpose of this study is to undertake a comprehensive systematic review to
describe multilevel factors (barriers and facilitators) that may influence the implementation of …

Rural populations have higher rates of smoking and both lung cancer incidence and
mortality compared with their urban peers. As such, it is imperative that high-risk, rural …

Background: Lung cancer is the leading cause of cancer-related deaths in the United States.
Despite mandated insurance coverage for eligible patients, lung cancer screening rates …

Importance Screening for lung cancer using low-dose computed tomography is associated
with reduced lung cancer–specific mortality, but uptake is low in the US; understanding how …